MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-2.52 Cr | ₹-1.88 Cr | ₹-0.50 Cr | ₹0.28 Cr | ₹0.16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MEDICAMEN BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-2.52 Cr |
Mar2023 | ₹-1.88 Cr |
Mar2022 | ₹-0.50 Cr |
Mar2021 | ₹0.28 Cr |
Mar2020 | ₹0.16 Cr |
How is Deferred Tax Assets / Liabilities of MEDICAMEN BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-2.52 Cr | Negative | |
Mar2023 | ₹-1.88 Cr | Negative | |
Mar2022 | ₹-0.50 Cr | Negative | |
Mar2021 | ₹0.28 Cr | 72.56 | |
Mar2020 | ₹0.16 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹475.7 Cr | -1.7% | -13.5% | -8.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,192.0 Cr | 0.3% | -4% | -6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,479.0 Cr | 2% | -9.6% | 33.1% | Stock Analytics | |
CIPLA | ₹125,113.0 Cr | 1.9% | 4.5% | -0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,539.0 Cr | 0.6% | 3.6% | 9.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,926.0 Cr | 2% | -1% | -7% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -1.7% |
-13.5% |
-8.8% |
SENSEX | 1.3% |
-0.8% |
3.2% |
You may also like the below Video Courses